Debra Barki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Debra Barki has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Scherz-Shouval
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
23 shared publications - Aviad Ben-Shmuel
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
22 shared publications - Coral Halperin
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
21 shared publications - Dana Morzaev-Sulzbach
Chaim Sheba Medical Center, Institute of Oncology, Tel-Hashomer, Israel
21 shared publications - Einav Nili Gal-Yam
Sheba Medical Center 17 Breast Oncology Institute Ramat Gan, Israel
21 shared publications - Gal Yagel
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
21 shared publications
Latest Publications
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 9 shows association of NK ligand expression on CAFs and patient outcomes in TNBC
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 9 shows association of NK ligand expression on CAFs and patient outcomes in TNBC
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 1 shows RNA-seq of NMFs from healthy mice and CAFs from mice harboring 4T1 tumors
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 1 shows RNA-seq of NMFs from healthy mice and CAFs from mice harboring 4T1 tumors
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 4 shows that NMFs and CAFs upregulate NK ligands following ex-vivo culture and are susceptible to NK cell-mediated lysis
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 4 shows that NMFs and CAFs upregulate NK ligands following ex-vivo culture and are susceptible to NK cell-mediated lysis